Differential Metabolic Effects of Fenofibrate and Fatty Acid

Gachon University Gil Medical Center

Status and phase: Completed; Phase 4

Conditions: Hypertriglyceridemia

Treatments: Drug: fenofibrate, fatty acid, placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT01003847

GMC-200911

Details and patient eligibility

About

The investigators hypothesize that fenofibrate and fatty acid may have different metabolic effects in hypertriglyceridemic patients

Enrollment: 150 patients

Sex: All

Ages: 25 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• hypertriglyceridemia

Exclusion criteria

• Overt liver disease Chronic renal failure Hypothyroidism Myopathy Uncontrolled diabetes Severe hypertension

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

150 participants in 3 patient groups

fenofibrate

Active Comparator group

Treatment:

Drug: fenofibrate, fatty acid, placebo

fatty acid

Active Comparator group

Description:

drug

Treatment:

Drug: fenofibrate, fatty acid, placebo

Placebo

Active Comparator group

Treatment:

Drug: fenofibrate, fatty acid, placebo